reference/3748753

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3748753

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1120
issn	1527-7755 0732-183X
issueIdentifier	9
pageRange	1114-1120
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	1114
bibliographicCitation	O'Brien S, Moore JO, Boyd TE, Larratt LM, Skotnicki A, Koziner B, Chanan-Khan AA, Seymour JF, Bociek RG, Pavletic S, Rai KR. Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia. J Clin Oncol. 2007 Mar 20;25(9):1114–20. doi: 10.1200/jco.2006.07.1191. PMID: 17296974.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbef71c6c9ee38c2d2fb7df759bcb6c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37061a75a5f68e7e4867163fbaefbba3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_525deaca6e55335a6215b6ad0097cf77 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a7a548b7c971441c38e08366cfc79a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_642403a49fde25a0f434de9f7f5b836e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_943bf35491e92fc101f85334f3197b14 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff824cbeab7457d12b4704c742dfcd9e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d2160e31c6e93e3b8266c66135cc969 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bea22749486edb2eb7c31e1c58705eb4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65a69d9695580cb9964a2809248b1629 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40a2d894364c8d1f8f34a3dacca2f150
date	2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/17296974 https://doi.org/10.1200/jco.2006.07.1191
isPartOf	https://portal.issn.org/resource/ISSN/1527-7755 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/0732-183X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
discusses	http://id.nlm.nih.gov/mesh/M0082555 http://id.nlm.nih.gov/mesh/M0362850 http://id.nlm.nih.gov/mesh/M0021363 http://id.nlm.nih.gov/mesh/M0025055 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0022659 http://id.nlm.nih.gov/mesh/M0028268
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015451Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D017211 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D019254 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D016016 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D015451Q000235 http://id.nlm.nih.gov/mesh/D012008 http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D014740Q000008 http://id.nlm.nih.gov/mesh/D015451Q000401 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D014740Q000031 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D016376Q000008 http://id.nlm.nih.gov/mesh/D018906Q000008 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D013873Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9689 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8703 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657237 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118984457 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9899 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118984458 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9720

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788769 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788477 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128814614 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24224 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127960150 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790210

Total number of triples: 82.